MetaCap

Capricor Therapeutics Statistics

NASDAQ: CAPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.59+0.06 (+0.80%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Capricor Therapeutics by the numbers

Capricor Therapeutics has a market capitalization of $441.3 million based on 58.14M shares outstanding. With trailing EPS of $-2.65, Capricor Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.4% below its 50-day average and 61.2% below its 200-day average.

Average daily trading volume is 4.73M shares, or about $35.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CAPR valuation vs. peer median

CAPR compared with the median of 8 peer companies
MetricCAPRPeer medianDifference
Market cap$441.30M$442.18M-0%
Avg. volume4.73M461.66K+925%

Peer median across 8 companies: AQST, LYEL, INDP, CTMX, EOLS, AMRN, DMAC, KMDA.

Valuation

Price and trading

Previous close
7.53
Open
8.16
Day range
7.38 – 8.34
52-week range
2.96 – 40.37
52-week change
+32.00%
Beta
—
Volume
10.65M

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
441.30M
Forward Pe
-5.30
Eps
-2.65
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
40.37
Week52 Low
2.96
Avg Volume
4.73M
Shares Outstanding
58.14M
Ma50
8.02
Ma200
19.57
Earnings Date
Nov 10, 2026
Pct From52w High
-81.20%
Pct From52w Low
156.42%

Related